GSS Share Price Performance
AU$0
-0.71 (-100.00%)
Price AU$0
Share Pricen/a
Even With A 26% Surge, Cautious Investors Are Not Rewarding Genetic Signatures Limited's (ASX:GSS) Performance Completely
Nov 08
Genetic Signatures Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
GSS Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Genetic Signatures Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.089
- 53.19%
- -101.78%
- 0%
About GSS
- Founded
- 2001
- Employees
- n/a
- CEO
- WebsiteView website
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
